乙型肝炎病毒前S2抗原决定簇（HBVPreS2epitope）与乙型肝炎病毒核心抗原（HBcAg）的基因融合与表达

乙肝前Ｓ２（ＨＢＶＰｒｅＳ２）肽段由５５个氨基酸组成,其Ｎ端肽段含Ｔｈ和Ｂ细胞抗原决定簇。我们将化学合成的ＰｒｅＳ２ｅｐｉｔｏｐｅ（１２０－１４５）基因与ＨＢｃＡｇ基因不同位点进行融合,融合基因在大肠杆菌中获得表达,并对融合蛋白进行了纯化。经ＥＬＩＳＡ和Ｗｅｓｔｅｒｎ－ｂｌｏｔ实验表明,融合蛋白具有ＰｒｅＳ２和ＨＢｃＡｇ两者的抗原性。此外,研究还表明,强启动子能使表达水平有一定提高。     

霍乱毒素B亚基融合蛋白表达系统的构建

霍乱毒素Ｂ亚基（ＣＴＢ）是良好的免疫佐剂和载体蛋白。本研究通过定点突变,在ＣＴＢ基因（ｃｔｘＢ）３＇端终止密码前引入了限制性内切酶ＥｃｏＲＩ,构建了质粒ＰＭＣ０５,ＰＭＣ０５中ＣＴＢ与下游ｌａｃＺ＇基因阅读框架相同,转化大肠杆菌后能够表达ＣＴＢ与β－半乳糖苷酶α肽的融合蛋白;所表达的融合蛋白能与ＧＭ１结合,说明融合蛋白保持ＣＴＢ的基本高级结构和生物学活性;融合蛋白能与抗－ＣＴＢ抗体结合,说明融合蛋     

免疫球蛋白变区基因的体外扩增及人—鼠嵌合抗体的表达

应用聚合酶链反应法体外扩增抗人小细胞肺癌单克隆抗体的变区基因,经核苷酸序列分析,轻链变基因为３２４ｂｐ,编码１０８个氨基酸,重链变区基因为３１５ｂｐ,编码１１７个氨基酸,将重变区基因克隆至ｐＳＶ２△ＨｇｐｔＨｕγ３质粒,经一系列克隆,筛选,得一插入方面正确的表达人－鼠嵌合重链抗体的载体－ｐＳＶ２△Ｈｇｐｔ２Ｆ７ＶＨＨｕγ３。用电穿孔方法将该粒导入鼠源骨髓瘤细胞Ｊ５８８Ｌ,用霉酚酸进行初步筛选,最终     

The inhibitory effect of transthyretin gene on growth of human hepatoma cells

Transthyretin(TTR) gene was highly expressed in normal liver and it has been found to be deleted in part of DNA samples from human hepatic cancer.Its mRNA expression was suppressed in most hepatoma samples.In order to study the biological effect of TTR gene on the growth of hepatoma cells,a recombinant vector containing TTR cDNA was constructed by pCMV,then it was transfected into hepatoma cell lines SMMC-7721 and Q3.It has been demonstrated that the inhibition of growth rate of TTR cDNA transfected hepatoma cells was about 50% in strength compared with that of the control.This inhibition was further enhanced when the transfected hepatoma cells were treated with all-trans retinoic acid.Hepatoma cells of cell lines PLC/PRF/5,SMMC-7721 and Q3 as well as hepatoma cells SMMC-7721 transfected with pCMV or pCMV-TTR were analyzed for TTR expression by Northern hybridization.The low level of TTR expression was found in both hepatoma cell lines and in SMMC-7721 cells transfected with pCMV alone.However,a remarkable TTR mRNA expression was observed in hepatoma SMMV-7721 cells transfected with pCMV-TTR.It seems possible that TTR gene might be a candidate of cancer suppressor gene for human hepatic cancer.     

A stage—specific protein factor binding to a CACCC motif in both human β—globin gene promoter and 5‘—HS2 region

The DNaseI hypersensitive site 2 (HS2) of human β-globin locus control region(LCR) is required for the high level expression of human β-globin genes.In the present study,a stage-specific protein factor (LPF-β) was identified in the nuclear extract prepared from mouse fetal liver at d 18 of gestation,which could bind to the HS2 region of human β-globin LCR.We also found that the shift band of LPF-β factor could be competed by human β-globin promoter.However,it couldn‘t be competed by human ε-globin promoter or by human ^Aγ-globin promoter.Furthermore,our data demonstrated that the binding-sequence of LPF-β factor is 5‘CACACCCTA 3‘,which is located at the HS2 region of β-LCR(from-10845 to-10853 bp)and human β-globin promoter(from-92 to -84 bp).We speculated that these regions containing the CACCC box in both the human β-globin promoter and HS2 might function as stage selector elements in the regulation of human β-globin switching and the LPF-β factor might be a stage-specific protein factor involved in the regulation of human β-globin gene expression.